DNLI

DENALI THERAPEUTICS INC

Healthcare | Mid Cap

-$0.86

EPS Forecast

$17.01

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon
REPLReplimune Group IncBLUEBluebird Bio IncCRSPCrispr Therapeutics AgHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncNBIXNeurocrine Biosciences IncNVAXNovavax IncRGENRepligen CorpTECHBio-techne CorpMRNAModerna Inc